An evidence-based hypothesis for beneficial effects of telmisartan on Marfan syndrome

Int J Cardiol. 2012 Jun 28;158(1):101-2. doi: 10.1016/j.ijcard.2012.03.051. Epub 2012 Mar 28.

Authors

Hisato Takagi, Hirotaka Yamamoto, Kotaro Iwata, Shin-Nosuke Goto, Takuya Umemoto; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group

PMID: 22459372
DOI: 10.1016/j.ijcard.2012.03.051

No abstract available

Publication types

Letter

MeSH terms

Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Benzimidazoles / therapeutic use*
Benzoates / therapeutic use*
Evidence-Based Medicine
Humans
Marfan Syndrome / drug therapy*
Telmisartan

Substances

Angiotensin II Type 1 Receptor Blockers
Benzimidazoles
Benzoates
Telmisartan